2018 Impact Report – Read how your support has made a difference When Jack Moon and David Guttman, as bladder cancer survivors, founded Bladder Cancer Canada in 2009, we might have hoped but had no idea that it would become what it is today. That’s why, during this 10th anniversary year, we’re pleased to share BCC’sRead more
Blog
IMPORTANT UPDATE – June 26, 2019 In early June Bladder Cancer Canada informed our medical and patient community across Canada that there would be a supply outage of Merck’s OncoTICE® strain of Bacillus Calmette-Guerin (BCG) between mid to late June and the end of July due to a manufacturing delay. Read the Bladder Cancer CanadaRead more
IMPORTANT UPDATE – AUGUST 8, 2019 Bladder Cancer Canada and its Medical Advisory Board were advised by Merck Canada back in November 2018 that they would be experiencing limited supply of Bacillus Calmette-Guerin (BCG) in the coming year. As the only supplier of BCG in Canada Merck established an allocation plan last fall and committedRead more